BC Advantage Funds
BC Advantage Funds is a venture capital firm that caters to early stage life science, technology, and clean tech companies. In 2006, the company received the Canadian Venture Capital Association 'Deal of the Year' award for achieving the highest realized return on a single investment (23.4X return on our investment in Aspreva Pharmaceuticals) of any venture capital firm in Canada. Furthermore, in the three years prior to its redemption (2006,2007, 2008), its Advantage Life Science Fund I provided the highest 5-year returns of any retail fund in Canada (Source: GlobeFund). Advantage most recent venture capital fund, the Advantage Structured Fund, was primarily raised and invested in the robust pre financial-crisis environment of 2004 – 2007. Since the financial crisis and recession of 2008 – 2009, we have had the challenging task of growing these businesses, keeping them financed despite difficult capital markets, and seeking profitable exits from the investments in a post financial-crisis environment characterized by few (if any) initial public offerings (IPOs), depressed activity in merger and acquisition (M&A) markets, and weakened valuations for emerging technology companies. In July, 2016, Advantage announced that its Board of Directors had concluded a review of strategic alternatives and determined that a liquidation and dissolution of the Company is the best alternative for maximizing shareholder value. The Board subsequently called an annual and special meeting of shareholders of the Company to approve a number of items, including the voluntary dissolution of the Company under Division 2 of Part 10 of the Business Corporations Act (British Columbia), the settlement of all of the assets of the Company on the Liquidation Trustee (as defined in the information circular in respect of the Meeting) on trust that the Trustee assume and pay all of the liabilities of the Company, and distribute all remaining assets of the Trust rateably to the shareholders of record. The Dissolution Resolution was approved by way of an ordinary and special resolution passed by a majority and at least two-thirds, respectively, of the votes cast by the Company’s shareholders the Meeting.
Redlen Technologies Inc. specializes in manufacturing cadmium zinc telluride (CZT) semiconductors, which are essential for radiation detection and imaging equipment used in various applications such as nuclear cardiology, CT scanning, baggage scanning, and bomb detection. Founded in 1999 and based in Saanichton, Canada, the company has pioneered a unique production process known as the Traveling Heater Method (THM) to create advanced CZT semiconductor wafers. This innovation enhances the performance, cost-efficiency, and availability of radiation detection technologies, facilitating their adoption in both medical and security sectors. Additionally, Redlen provides high-purity cadmium telluride feedstock solutions for thin film solar photovoltaic applications, thereby contributing to the renewable energy market. With a strong focus on advancing semiconductor and imaging technology, Redlen Technologies is positioned as a leader in high-performance detection solutions.
MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in the development of innovative medical devices. The company has created CoagMax, a point-of-care monitor that enables patients to conduct PT/INR testing at home, facilitating self-monitoring of blood coagulation levels. This device utilizes advanced micro electro mechanical sensors embedded in a disposable smart strip, allowing for a convenient, safe, and accurate testing experience. By focusing on patient-friendly solutions, MicroVisk aims to improve the quality of life for individuals requiring regular blood coagulation monitoring.
Redlen Technologies Inc. specializes in manufacturing cadmium zinc telluride (CZT) semiconductors, which are essential for radiation detection and imaging equipment used in various applications such as nuclear cardiology, CT scanning, baggage scanning, and bomb detection. Founded in 1999 and based in Saanichton, Canada, the company has pioneered a unique production process known as the Traveling Heater Method (THM) to create advanced CZT semiconductor wafers. This innovation enhances the performance, cost-efficiency, and availability of radiation detection technologies, facilitating their adoption in both medical and security sectors. Additionally, Redlen provides high-purity cadmium telluride feedstock solutions for thin film solar photovoltaic applications, thereby contributing to the renewable energy market. With a strong focus on advancing semiconductor and imaging technology, Redlen Technologies is positioned as a leader in high-performance detection solutions.
MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in the development of innovative medical devices. The company has created CoagMax, a point-of-care monitor that enables patients to conduct PT/INR testing at home, facilitating self-monitoring of blood coagulation levels. This device utilizes advanced micro electro mechanical sensors embedded in a disposable smart strip, allowing for a convenient, safe, and accurate testing experience. By focusing on patient-friendly solutions, MicroVisk aims to improve the quality of life for individuals requiring regular blood coagulation monitoring.
Zeugma Systems is a privately held telecommunications equipment supplier delivering open solutions that accelerate new service deployment for broadband service providers of all types. The Zeugma Services Node, a service delivery router (SDR), uniquely combines massive compute resources with next-generation capacity, service awareness, and subscriber awareness in a carrier-grade, fully redundant system. The result is a new class of equipment that enables service providers to: Rapidly prototype and launch new revenue-generating services and network behaviors, Identify and monitor session flows on a highly granular per-subscriber, per-service basis, Manage individual session flows in order to enforce policy-based quality of service (QOS), Develop applications, such as targeted ad insertion, that add value to individual session flows, Reduce the number and types of edge devices required to deliver high-value services while performing, standard broadband aggregation and subscriber management functions.
Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body's innate defenses without causing inflammation.
NPS was founded in November 2003 in order to exploit polymer technology invented and developed by UK Government research laboratories. Having established an exclusive licence to the technology, NPS has been working to apply it to specific applications across many industries.
Mobidia Technology, Inc. specializes in mobile app and network usage data solutions, offering insights that help businesses track competitors and optimize their services. Founded in 2004 and based in Richmond, Canada, the company provides a comprehensive analytics platform that delivers real usage data worldwide. By analyzing trends in mobile and Wi-Fi data, Mobidia enables companies to enhance their advertising strategies, refine data plans, and improve over-the-top service offerings. The firm's popular My Data Manager application assists smartphone users in managing their data consumption, leading to cost savings on mobile plans while also supporting mobile operators in increasing revenue and reducing operational costs. As of 2015, Mobidia operates as a subsidiary of App Annie Limited.
Zeugma Systems is a privately held telecommunications equipment supplier delivering open solutions that accelerate new service deployment for broadband service providers of all types. The Zeugma Services Node, a service delivery router (SDR), uniquely combines massive compute resources with next-generation capacity, service awareness, and subscriber awareness in a carrier-grade, fully redundant system. The result is a new class of equipment that enables service providers to: Rapidly prototype and launch new revenue-generating services and network behaviors, Identify and monitor session flows on a highly granular per-subscriber, per-service basis, Manage individual session flows in order to enforce policy-based quality of service (QOS), Develop applications, such as targeted ad insertion, that add value to individual session flows, Reduce the number and types of edge devices required to deliver high-value services while performing, standard broadband aggregation and subscriber management functions.
Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.
Contigo helps people manage and secure the things important to them using advanced wireless and location technologies. They develop and manage the industry’s leading location-based services platform for asset-tracking, fleet management and lone worker safety applications. They deliver their suite of products to value-added resellers, major wireless carriers and enterprise customers, leveraging their rapid-cycle product development processes and their patented SaaS platform. Founded in 2002, Contigo is a privately held corporation based in Vancouver, British Columbia with U.S. operations headquartered in Santa Monica, California.
Mobidia Technology, Inc. specializes in mobile app and network usage data solutions, offering insights that help businesses track competitors and optimize their services. Founded in 2004 and based in Richmond, Canada, the company provides a comprehensive analytics platform that delivers real usage data worldwide. By analyzing trends in mobile and Wi-Fi data, Mobidia enables companies to enhance their advertising strategies, refine data plans, and improve over-the-top service offerings. The firm's popular My Data Manager application assists smartphone users in managing their data consumption, leading to cost savings on mobile plans while also supporting mobile operators in increasing revenue and reducing operational costs. As of 2015, Mobidia operates as a subsidiary of App Annie Limited.
MetroBridge Networks Corporation is a privately held company that specializes in delivering broadband wireless access through advanced technologies. The company operates a redundant microwave network capable of providing internet connections of up to 100 Mbps across its coverage area and up to 1 Gbps in urban centers. Formed from the merger of two leading broadband wireless providers, Universco and AirCelerator, MetroBridge focuses on serving a diverse clientele, including stand-alone businesses, multi-tenant commercial customers, and temporary locations such as construction sites and film productions. Earlier this year, MetroBridge achieved recognition as the first Canadian broadband wireless access provider to be accepted into the WiMAX Forum, underscoring its commitment to innovation in the wireless broadband industry.
Mobidia Technology, Inc. specializes in mobile app and network usage data solutions, offering insights that help businesses track competitors and optimize their services. Founded in 2004 and based in Richmond, Canada, the company provides a comprehensive analytics platform that delivers real usage data worldwide. By analyzing trends in mobile and Wi-Fi data, Mobidia enables companies to enhance their advertising strategies, refine data plans, and improve over-the-top service offerings. The firm's popular My Data Manager application assists smartphone users in managing their data consumption, leading to cost savings on mobile plans while also supporting mobile operators in increasing revenue and reducing operational costs. As of 2015, Mobidia operates as a subsidiary of App Annie Limited.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.